Advertise with us
Clinical Group

Global Journal of Obesity, Diabetes and Metabolic Syndrome

    Abstract Open Access
    Short Communication PTZAID: GJODMS-4-116

    Nutrigenomics Coupling with other OMICS Platform Enhance Personalized Health Care in Metabolic Disorders

    Sylvester Ndimele, Miranda L. Carpenter, Jae-Hyeon Cho and Hong Duck Kim*

    Diabetes is a multifactorial of diseases characterized by high blood glucose levels which occur as a result in the body’s inability to produce and/or use insulin. Both type 1 and 2 diabetes are thought to be complex disease which developed by the influence of many susceptibility and protective genes, in relation with negative and positive environmental factors. Though type 1 diabetes is distinguished by common beta-cell loss which is mediated by an autoimmune process to extent that all patients with overt type 1 diabetes will essentially need insulin. Multiple genetic factors have been connected to type 1 diabetes which can define individualized plan for type 1 prevention. This review has focused on type 2 diabetes (T2D) which has become more and more a challenging health burden as a result of its degree of morbidity, mortality and heightened prevalence worldwide.

    Published on: Feb 3, 2017 Pages: 5-8

    Full Text PDF Full Text HTML DOI: 10.17352/2455-8583.000016

    Advertisements

    Google Ads

    Peertechz @Social

    Peertechz Tweets

    Case Reports

    Pinterest on GJODMS